Press Releases
November 14th, 2024
Stilla Technologies with Source BioScience Brings Advanced Genomics Solutions to the UK Market
About Stilla Technologies Stilla Technologies is a pioneering biotech company, specializing in providing next-generation digital PCR solutions that offer enhanced…
September 17th, 2024
Stilla Technologies Partners with Niba Labs to Accelerate Development of Advanced Digital PCR Assays for Cell and Gene Therapy, Strengthen Industry Research, and Expand Analytical Testing
Paris – September 17, 2024 –Stilla Technologies, a leader in digital PCR (dPCR) solutions, is pleased to announce a strategic…
June 27th, 2024
Stilla Technologies Expands Product Portfolio with Two New Digital PCR Configurations for the Nio™ Product Line
Paris and Boston, June 27, 2024 – Stilla Technologies, a leader in multiplex digital PCR technology, proudly announces the addition…
June 6th, 2024
Stilla Technologies Expands U.S. Presence Through Strategic Distribution Relationship with Avantor and Introduces Advanced Content Offerings
• Stilla Technologies expands in the U.S. via a strategic distribution relationship with Avantor, making their digital PCR products more…
February 22nd, 2024
Stilla Technologies closes $26.5M Series C financing to accelerate commercialization of its digital PCR platform – expands leadership team
PARIS and BOSTON, February 22, 2023 – Today, Stilla Technologies, the start-up leading innovations in digital PCR, announced it has…
April 18th, 2023
Stilla Technologies adds 20 new liquid biopsy kits to its reagents portfolio from partner ApexBio
BURLINGTON, MA – Stilla Technologies today announced the availability of 20 new digital PCR assays, optimized for its Crystal Digital…
March 30th, 2023
Stilla Technologies and Atila BioSystems to co-develop high-plex digital PCR kits for onocology
Stilla Technologies and Atila BioSystems today announced an agreement to market digital PCR kits and assays produced by Atila BioSystems…
March 20th, 2023
New Stilla Ruby Chip and naica® system 21 CFR Part 11 compliance enable full automation of digital PCR testing for clinically-oriented applications
BOSTON, MA (March 2, 2023) – Stilla Technologies, the multiplex digital PCR company, has recently introduced the Ruby Chip, the…
August 2nd, 2022
Stilla Technologies solidifies leadership in EMEA, expands footprint in APAC
PARIS & BOSTON–Stilla Technologies, the multiplex digital PCR company, announces the addition of Yvan Sergeant to serve in the capacity…
April 6th, 2022
Stilla and Promega Announce Co-Marketing Agreement to Offer Complete Digital PCR Workflow Solution
BOSTON–Stilla Technologies, the multiplex digital PCR company, and Promega Corporation today announced a co-marketing agreement that combines sample preparation with…